VBS-96083-38965
2 vaccinations
4 coded responses
16 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 894 / NV
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-27
Registered in v-safe
-
2020-12-27
Dose 1 — Moderna
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-01
- 2021-01-02
- 2021-01-05
- 2021-01-10
- 2021-01-17
-
2021-01-24
Dose 2 — Moderna
-
2021-02-20
Survey response — day 21, dose 2MedDRA: Chills, Pain — Feeling: GoodFree text: Body aches and chills the first 48 hours after the second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-02-28
- 2021-03-07
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Fatigue, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fever 101.9FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-25
Survey response — 6 months, dose 2MedDRA: Cardiac ablation, Supraventricular tachycardia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: SVT · Healthcare visit (other): Cardiac ablationMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-25
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-26
-
2022-01-24
Survey response — 12 months, dose 2MedDRA: Chest pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chest painMedDRA releases: 2024-11 · check-in free text available
-
2022-01-24
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Moderna | |
| 2 | 2021-01-24 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-25 | Unsuccessful | |
| 2022-01-24 | Unsuccessful |
Free text
Release 4 — day 21, dose 2
Symptoms: Body aches and chills the first 48 hours after the second dose
Release 8 — 3 months, dose 2
Symptoms: Fever 101.9Fatigue
Release 9 — 6 months, dose 2
Release 11 — 12 months, dose 2
Symptoms: Chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Cardiac ablation | ✓ | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Supraventricular tachycardia | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release